GlassScriptPhysician profile
Jesus P Querubin
NPI 1609965375
$10,554.62
in general payments reported to CMS, 2019-2025
32 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,567 · 2020: $1,209 · 2021: $2,284 · 2022: $1,692 · 2023: $1,235 · 2024: $1,140 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,794 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,794.09 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,818.17 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $1,460.58 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $1,398.24 | 2021-2025 | |
| Novo Nordisk INC | $1,310.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $633.73 | 2019-2023 | |
| Redhill Biopharma INC. | $609.96 | 2020-2022 | |
| Allergan, INC. | $373.57 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.90 | 2019-2025 | Jardiance |
| Arbor Pharmaceuticals, INC. | $307.19 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $246.79 | 2019-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $243.75 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $235.01 | 2023-2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $233.68 | 2021-2022 | |
| Axsome Therapeutics, INC. | $207.11 | 2023-2025 | Sunosi, Auvelity |
| Regeneron Healthcare Solutions, INC. | $179.23 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $170.69 | 2022-2023 | |
| Lilly USA, LLC | $148.64 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $146.12 | 2019-2025 | Breztri, Airsupra, Bevespi Aerosphere |
| Takeda Pharmaceuticals U.S.A., INC. | $103.87 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $69.15 | 2021 | |
| Philips North America LLC | $54.94 | 2023 | |
| Sanofi-Aventis U.S. LLC | $51.39 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.71 | 2021-2023 | Xifaxan, Trulance |
| Mylan Specialty L.P. | $30.11 | 2021-2022 | |
| Optinose US, INC. | $28.17 | 2021 | |
| Verona Pharma, INC. | $19.06 | 2025 | Ohtuvayre |
| Lundbeck LLC | $18.35 | 2025 | Rexulti |
| Concordia Pharmaceuticals INC. | $16.90 | 2019 | |
| Valinor Pharma, LLC | $16.71 | 2025 | Movantik |
| Phathom Pharmaceuticals, INC. | $16.62 | 2024 | Voquezna |
| Pfizer INC. | $14.38 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Querubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.